↓ Skip to main content

Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients

Overview of attention for article published in The Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients
Published in
The Journal of Law, Medicine & Ethics, January 2021
DOI 10.1111/j.1748-720x.2008.290.x
Pubmed ID
Authors

George T. H. Ellison, Jay S. Kaufman, Rosemary F. Head, Paul A. Martin, Jonathan D. Kahn

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 15%
Professor 2 8%
Student > Ph. D. Student 2 8%
Researcher 2 8%
Student > Master 2 8%
Other 4 15%
Unknown 10 38%
Readers by discipline Count As %
Social Sciences 3 12%
Medicine and Dentistry 3 12%
Engineering 2 8%
Agricultural and Biological Sciences 2 8%
Nursing and Health Professions 1 4%
Other 6 23%
Unknown 9 35%